Vascular Biogenics Ltd (VBLT)

[Oren1976]

I cant even think of a possibility that vb111 will fail the interim analysis. The interim is after 105 events and 1 year treatment to half patients this is plenty of time for the drug to work. I saw mri of patients on their drug. Metastasis disappeared and some patients showed tumor totally disappeared . They had a patient in phase 1 that the tumor disappeared after first treatment and didn't come back for years. When they were at even not middle phase 2 the fda looked at the MRI and said they never see anything like that before in rgbm and urged them to start ph3 before finishing the ph2. Results like that in the ph2 is around 0.something% chance . Looking at past phase 2 there were over 70 none showed that not even 1/70 so what is the real chance of such success in rgbm ? And u want to tell me it won't pass the interim. Are u kidding me? Zero chance